Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Happy Pre pre Thanksgiving Perker. Nice day yesterday for XXII. Couldn’t find any news and it’s been very quiet. I’d love for you to raise your batting average on these predictions.
We are sitting on a winner ,IMO. The FDA announcement in July was a game changer. We patiently wait, and hopefully enjoy a wonderful Thanksgiving? Christmas?
New Years ?
A perker prediction. Hang on for a wild ride. No stop losses , they’ll get taken out
Dw king. Just curious, How long have you owned this stock ?
Be patient. IMO we are in for some very exciting times in the very near future.
Looking forward to a positive CC. We’ve come a long ways, recalling our Sabby days .
Thanks for posting. Nice exposure for XXII
Perker,
I’m seeing earnings will be reported this Monday ,Nov 6 th after the close . Where do you get your information?
I don’t think they’ve formally announced a date for the CC. I’m hearing possibly Nov 9,
Good to hear from the old timers on this stock . I think there are a few of us still hanging on. I like how the story is unfolding .
Just check out any of perker’s posts and the SP after .
Good is bad,,, bad is good ,,,up is down with Perker ,,,,I like perker’s message
Yes. I think we will . Still holding all of my shares . It's been a long ride .
Perker,
Ive been here since your Christmas in July prediction years ago . What's going on with this latest prediction?
Thanks for the link . Hoping for a PR.
They've pulled out of a conference and IR isn't answering calls or emails. Pretty quiet around xxii .
I'm trying not to get too excited about the possibility of a buyout, however xxii has so much to offer the highest bidder. Can anyone come up with a reason for pulling out of this conference at this time and their upcoming trip to Europe?
They are no longer listed as presenters.
Quiet period?
4.8 million shares traded today....
Parker,
Any idea why 22nd century pulled out of Monday's conference? Where you aware of this ? Are you at liberty to say ?
Big volume and quick rise to 1.88. I guess we'll find out what was behind this jump in volume and SP.
I missed my fill at .78, I'm done waiting for pennies. Already have a substantial position, however I just can't pass up these prices with so many catalysts approaching.
http://www.ftserussell.com/files/support-documents/preliminary-rmicro-additions-2017
Has this been brought up, XXII's addition to the Russell? Any impact on SP?
Nice day so far on decent volume. Great sign to hold its gains for the week.
You could MXAMDUD, Just sell those imaginary shares the same way you bought them.
Just read the CC transcript. Very excited for the remainder of 2017. I'm hoping this starts trading soon.
Same for me. CTIX not recognized. Same with IPIX
Quick drop today to 1.65 but nice rebound to close at 1.84. Huge volume again . Hopefully we break through $2 and continue northward.
22nd Century Produces Non-GMO Very Low Nicotine Tobacco
Non-GMO tobacco varieties will open new markets worldwide
June 06, 2017 01:30 PM Eastern Daylight Time
CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group, Inc. (NYSE MKT:XXII), a plant biotechnology company that is focused on tobacco harm reduction and cannabis research, announced today that the Company’s research collaboration with North Carolina State University has yielded several new Very Low Nicotine (VLN) tobacco varieties that contain no foreign DNA and no trace of genetic modification. The new Very Low Nicotine varieties are ideally suited for use in the Company’s X-22 smoking cessation product in development and will also form the basis of other unique 22nd Century VLN products.
“Because our new non-GMO varieties contain no foreign DNA, these proprietary varieties will open up huge new markets around the world. What’s more, 22nd Century’s second-generation non-GMO VLN tobacco varieties produce an even higher quality tobacco that will further improve our Very Low Nicotine finished products.”
Tweet this
In the United States, federal regulation will not treat the new Very Low Nicotine tobacco varieties as “genetically modified;” further, these new proprietary tobacco strains will not be subject to burdensome regulation and import restrictions in most countries around the world. Representing a major improvement on the Company’s already successful Very Low Nicotine tobacco, the new proprietary varieties hold immense promise to open up large international markets for the Company. 22nd Century is already in contact with marketers and distributors in countries with GMO restrictions (Japan, India, and Korea) to facilitate the import of products based on the Company’s new non-GMO Very Low Nicotine tobaccos.
These second generation non-GMO VLN tobacco varieties also show improved ripening and curing qualities. 22nd Century’s new non-GMO Very Low Nicotine tobaccos not only lack foreign DNA, but they are also based on superior foundational varieties. One of 22nd Century’s new non-GMO lines is based on a flue cured variety known for its superior growing characteristics and curability, while another of the Company’s non-GMO lines is based on one of the most widely grown air-cured burley tobaccos that has excellent disease resistance and yield potential. These new non-GMO Very Low Nicotine tobacco varieties are already under cultivation and study in the Company’s laboratories in Buffalo, New York. 22nd Century anticipates having commercial quantities of seed for the non-GMO varieties by 2018.
The non-GMO Very Low Nicotine tobacco varieties are protected by numerous patents under 22nd Century’s extensive patent portfolio. The Company’s patents also protect additional second generation varieties that are currently in development for the Company at North Carolina State University and in 22nd Century’s own laboratories.
“We are absolutely delighted that we have achieved our goal of producing non-GMO Very Low Nicotine tobacco,” explained Dr. Paul Rushton, 22nd Century’s Vice President for Plant Biotechnology. “Because our new non-GMO varieties contain no foreign DNA, these proprietary varieties will open up huge new markets around the world. What’s more, 22nd Century’s second-generation non-GMO VLN tobacco varieties produce an even higher quality tobacco that will further improve our Very Low Nicotine finished products.”
Professor Ralph Dewey, the Principal Investigator at North Carolina State University, stated, “We are extremely pleased that our project with 22nd Century has been such a success. These exciting new varieties will create important new Very Low Nicotine tobacco products that will avoid the GMO label. We are also pleased that our projects with 22nd Century are ongoing and that we very well may produce exciting additional VLN varieties in the coming months.”
About 22nd Century Group, Inc.
22nd Century is a plant biotechnology company focused on technology which allows it to increase or decrease the level of nicotine in tobacco plants and the level of cannabinoids in cannabis plants through genetic engineering and plant breeding. The Company’s primary mission in tobacco is to reduce the harm caused by smoking. The Company’s primary mission in cannabis is to develop proprietary cannabis strains for important new medicines and agricultural crops. Visit www.xxiicentury.com and www.botanicalgenetics.com for more information.
Cautionary Note Regarding Forward-Looking Statements: This press release contains forward-looking information, including all statements that are not statements of historical fact regarding the intent, belief or current expectations of 22nd Century Group, Inc., its directors or its officers with respect to the contents of this press release, including but not limited to our future revenue expectations. The words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend” and similar expressions and variations thereof are intended to identify forward-looking statements. We cannot guarantee future results, levels of activity or performance. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances, or to reflect the occurrence of unanticipated events. You should carefully review and consider the various disclosures made by us in our annual report on Form 10-K for the fiscal year ended December 31, 2016, filed on March 8, 2017, including the section entitled “Risk Factors,” and our other reports filed with the U.S. Securities and Exchange Commission which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected.
Contacts
22nd Century Group
Investor Relations:
IRTH Communications
Andrew Haag, 866-976-4784
xxii@irthcommunications.com
22ND CENTURY GROUP, INC.
Steady climb on big volume . I'm not seeing anything in regards to news. I suppose we'll find out soon .
Any thoughts on yesterday's news?
Nice to see you back Pete
I agree with this post.
Time to make it happen
Lots of good stuff on stocktwits about meeting. Anybody attend? They're saying PR on Monday regarding FDA and brand B?
Got 70,71 and 74. Nice sale today. Weak hands gone. Pretty large drop due to pre recorded CC. And P got pushed back 1 quarter? continue the FUD rabbit.
I can use a few more shares . Find me another stock in the .70's with a pipeline like CTIX.
I'll take either . Lots of possibilities here .
Buying opp. Until the science changes, I'm buying . The rest is noise. Down this big because of a prerecorded CC?
Seems like news everyday. Decent volume on an up day. Imagine real news.
Some after hours action,50k traded at 1.28, 136,500 at 1.26,,
Any thoughts on today's volume and increase in SP? News about conference in Colorado?
It's been a long wait, however I think this may be the year for XXII
Do you think BAT will license? Do you think HS would have made this deal with BAT ? I'm hoping they don't license.
Thanks for sharing. Are we still flying under the radar ?